share_log

Cosmos Health | 8-K: Cosmos Health Announces Acquisition of Licenses and Rights to 10 Generic Drugs for €3.2 Million

SEC announcement ·  Jan 22 13:00
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.